Interactive chart of Teva Pharmaceutical Industries (TEVA) annual worldwide employee count from 2010 to 2023.
| Teva Pharmaceutical Industries Annual Employee Count | |
|---|---|
| 2023 | 37,851 |
| 2022 | 36,826 |
| 2021 | 37,537 |
| 2020 | 40,216 |
| 2019 | 40,039 |
| 2018 | 42,535 |
| 2017 | 51,792 |
| 2016 | 56,960 |
| 2015 | 42,888 |
| 2014 | 43,000 |
| 2013 | 45,000 |
| 2012 | 45,948 |
| 2011 | 45,754 |
| 2010 | 39,660 |
| 2009 | 35,089 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Generic Drugs | $14.933B | $15.846B |
| Teva Pharmaceutical Industries Limited is a global pharmaceutical company that develops, manufactures, and markets both branded and generic drugs, as well as active pharmaceutical ingredients in North America, Europe, Latin America, India, and Israel. Teva's generic product portfolio includes tablets, capsules, liquids, ointments, creams, liquids, injectables, and inhalants. The company's branded products include Copaxone, Austedo, respiratory products like ProAir and Qvar and Ajovy. Teva operates through three segments, North America, Europe and International Markets, each of which includes generics, specialty and over-the-counter products. Teva acquired Allergan's generics business Actavis Generics. The company also acquired Allergan's Anda Inc. Teva acquired Auspex Pharmaceuticals and Barr. Teva has strengthened its position in Europe through its acquisition of Germany's second largest generics producer, ratiopharm. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dr Reddy's Laboratories (RDY) | India | $12.597B | 19.92 |
| Aspen Pharmacare (APNHY) | South Africa | $4.995B | 0.00 |
| BridgeBio Pharma (BBIO) | United States | $4.890B | 0.00 |
| CymaBay Therapeutics (CBAY) | United States | $3.724B | 0.00 |
| Bausch Health Cos (BHC) | Canada | $3.428B | 2.67 |
| Amphastar Pharmaceuticals (AMPH) | United States | $2.061B | 14.33 |
| Supernus Pharmaceuticals (SUPN) | United States | $1.871B | 0.00 |
| Taysha Gene Therapies (TSHA) | United States | $0.398B | 0.00 |
| Generation Bio (GBIO) | United States | $0.197B | 0.00 |
| Personalis (PSNL) | United States | $0.082B | 0.00 |
| Assembly Biosciences (ASMB) | United States | $0.065B | 0.00 |
| hom*ology Medicines (FIXX) | United States | $0.052B | 0.00 |
| Acasti Pharma (ACST) | Canada | $0.032B | 0.00 |
| Sol-Gel Technologies (SLGL) | Israel | $0.029B | 0.00 |
| Evoke Pharma (EVOK) | United States | $0.002B | 0.00 |
| Agile Therapeutics (AGRX) | United States | $0.002B | 0.00 |
| Teligent (TLGT) | United States | $0.000B | 0.00 |
